These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12202622)

  • 1. The discovery and confirmation of single nucleotide polymorphisms in the human p53R2 gene by EST database analysis.
    Ye Z; Parry JM
    Mutagenesis; 2002 Sep; 17(5):361-4. PubMed ID: 12202622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of polymorphisms in the human Reprimo gene using public EST data.
    Ye Z; Parry JM
    Teratog Carcinog Mutagen; 2002; 22(6):485-93. PubMed ID: 12395409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene.
    Ulrich CM; Bigler J; Velicer CM; Greene EA; Farin FM; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1381-5. PubMed ID: 11142426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a functional polymorphism in human glutathione transferase zeta by expressed sequence tag database analysis.
    Blackburn AC; Tzeng HF; Anders MW; Board PG
    Pharmacogenetics; 2000 Feb; 10(1):49-57. PubMed ID: 10739172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage.
    Tanaka H; Arakawa H; Yamaguchi T; Shiraishi K; Fukuda S; Matsui K; Takei Y; Nakamura Y
    Nature; 2000 Mar; 404(6773):42-9. PubMed ID: 10716435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and mutation analyses of P53R2, a newly identified p53 target for DNA repair in human gastric carcinoma.
    Byun DS; Chae KS; Ryu BK; Lee MG; Chi SG
    Int J Cancer; 2002 Apr; 98(5):718-23. PubMed ID: 11920641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infrequent alteration in the p53R2 gene in human transitional cell carcinoma of the urinary tract.
    Hayashi H; Furihata M; Kuwahara M; Kagawa S; Shuin T; Ohtsuki Y
    Pathobiology; 2004; 71(2):103-6. PubMed ID: 14707445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis and functions of p53R2 in zebrafish.
    Shang H; Li Q; Feng G; Cui Z
    Gene; 2011 Apr; 475(1):30-8. PubMed ID: 21194559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A second generation framework for the analysis of microsatellites in expressed sequence tags and the development of EST-SSR markers for a conifer, Cryptomeria japonica.
    Ueno S; Moriguchi Y; Uchiyama K; Ujino-Ihara T; Futamura N; Sakurai T; Shinohara K; Tsumura Y
    BMC Genomics; 2012 Apr; 13():136. PubMed ID: 22507374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel PCR-RFLP assay for the detection of a polymorphism in the 3' of STAT6 gene.
    Amoli M; Ollier WE; Hajeer AH
    Genes Immun; 2000 Jun; 1(5):349-50. PubMed ID: 11196699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel polymorphism (-88 C>A) in the 5' UTR of the p53R2 gene.
    Smeds J; Nava M; Kumar R; Hemminki K
    Hum Mutat; 2001; 17(1):82. PubMed ID: 11139269
    [No Abstract]   [Full Text] [Related]  

  • 12. The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53.
    Zhou B; Liu X; Mo X; Xue L; Darwish D; Qiu W; Shih J; Hwu EB; Luh F; Yen Y
    Cancer Res; 2003 Oct; 63(20):6583-94. PubMed ID: 14583450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel genetic variations of the p53R2 gene in patients with colorectal adenoma and controls.
    Deng ZL; Xie DW; Bostick RM; Miao XJ; Gong YL; Zhang JH; Wargovich MJ
    World J Gastroenterol; 2005 Sep; 11(33):5169-73. PubMed ID: 16127747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F1 regulates p53R2 gene expression in p53-deficient cells.
    Qi JJ; Liu L; Cao JX; An GS; Li SY; Li G; Jia HT; Ni JH
    Mol Cell Biochem; 2015 Jan; 399(1-2):179-88. PubMed ID: 25312903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian p53R2 protein forms an active ribonucleotide reductase in vitro with the R1 protein, which is expressed both in resting cells in response to DNA damage and in proliferating cells.
    Guittet O; Håkansson P; Voevodskaya N; Fridd S; Gräslund A; Arakawa H; Nakamura Y; Thelander L
    J Biol Chem; 2001 Nov; 276(44):40647-51. PubMed ID: 11517226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint.
    Yamaguchi T; Matsuda K; Sagiya Y; Iwadate M; Fujino MA; Nakamura Y; Arakawa H
    Cancer Res; 2001 Nov; 61(22):8256-62. PubMed ID: 11719458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p53R2, newly p53 target in oral normal epithelium, epithelial dysplasia and squamous cell carcinoma.
    Yanamoto S; Kawasaki G; Yoshitomi I; Mizuno A
    Cancer Lett; 2003 Feb; 190(2):233-43. PubMed ID: 12565178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphic insertion of additional repeat within an area of direct 8 bp tandem repeats in the 5'-untranslated region of the p53R2 gene and cancer risk.
    Smeds J; Kumar R; Hemminki K
    Mutagenesis; 2001 Nov; 16(6):547-50. PubMed ID: 11682647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEK2 regulates ribonucleotide reductase activity through functional interaction with ribonucleotide reductase small subunit p53R2.
    Piao C; Youn CK; Jin M; Yoon SP; Chang IY; Lee JH; You HJ
    Cell Cycle; 2012 Sep; 11(17):3237-49. PubMed ID: 22895183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of the p53-p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis.
    Yoshida T; Haga S; Numata Y; Yamashita K; Mikami T; Ogawa T; Ohkusa T; Okayasu I
    Int J Cancer; 2006 Mar; 118(6):1395-403. PubMed ID: 16206288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.